Unknown

Dataset Information

Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.


ABSTRACT:

Aim

During the pandemic of coronavirus disease 2019 (COVID-19), the physicians are using various off-label therapeutics to manage COVID-19. We undertook a cross-sectional survey to study the current variation in therapeutic strategies for managing severe COVID-19 in India.

Methods

From January 4 to January 18, 2021, an online cross-sectional survey was conducted among physicians involved in the management of severe COVID-19. The survey had three sections: 1. Antiviral agents, 2. Immunomodulators, and 3. Adjuvant therapies.

Results

1055 respondents (from 24 states and five union territories), of which 64.2% were consultants, 54.3% working in private hospitals, and 39.1% were from critical care medicine completed the survey. Remdesivir (95.2%), antithrombotics (94.2%),

SUBMITTER: Jagiasi B 

PROVIDER: S-EPMC8420329 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature